BASSINDALE, Thomas (2011). Benzylpiperazine: the New Zealand legal perspective. Drug Testing and Analysis, 3 (7-8), 428-429.
Full text not available from this repository.
Link to published version:: https://doi.org/10.1002/dta.314
Abstract
In 2005 the New Zealand Government created a new schedule of ‘Restricted Substances’ under the Misuse of Drugs Act (1975). Benzylpiperazine was the first drug to be classified as what became known informally as ‘Class D’. The rationale behind that decision and the subsequent reclassification of benzylpiperazine to Class C, in 2008, is discussed.
Item Type: | Article |
---|---|
Research Institute, Centre or Group - Does NOT include content added after October 2018: | Biomedical Research Centre |
Identification Number: | https://doi.org/10.1002/dta.314 |
Page Range: | 428-429 |
Depositing User: | Rebecca Jones |
Date Deposited: | 08 Feb 2012 17:01 |
Last Modified: | 18 Mar 2021 20:30 |
URI: | https://shura.shu.ac.uk/id/eprint/4495 |
Actions (login required)
View Item |
Downloads
Downloads per month over past year